Trials / Sponsors / Synairgen Research Ltd.
Synairgen Research Ltd.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection Viral Pneumonia | Phase 2 | 2025-09-02 |
| Completed | Pilot Test of COVID-19 Related Clinical Outcome Assessment Methodology and Qualitative Evidence of Content Val COVID-19 | — | 2021-11-15 |
| Completed | Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 | Phase 3 | 2021-01-12 |
| Completed | Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection SARS-CoV-2 | Phase 2 | 2020-03-16 |
| Completed | A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2018-01-29 |
| Completed | Comparing Efficacy and Safety of Inhaled SNG001 to Placebo Asthma | Phase 2 | 2010-03-01 |